Partners and Collaborators

SDG's business model includes the creation of technology-focused companies that operate from licenses to SDG technology applications. AMDG, Inc., Diasome Pharmaceuticals, Inc. (www.diasome.com), and Targeted Nano Therapeutics (www.tntpharma.com) are representative of new companies that SDG has been instrumental in forming and managing. SDG is also pleased to be an Equity Partner Company of the Cleveland Clinic Foundation (www.ccf.org/innovations) and a resident company in the Clinic's new Global Cardiovascular Innovation Center.

SDG's delivery technologies are available for in-licensing. For more information, Please email us at info@sdgpharma.com